Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aldevit
- Development stage
- Unknown
- Lead developer
- Alde Medi Impex
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
Aldevit is an oral nutraceutical product developed and marketed by Allde Medi Impex. It is formulated as a syrup containing a combination of protein, iron, zinc, and various minerals. The product is positioned as a dietary supplement to support general nutritional needs, particularly in cases of deficiency or increased physiological demand. As a multi-ingredient formulation, it provides essential macronutrients and micronutrients to support overall metabolic health, erythropoiesis (via iron), and immune function (via zinc). It is categorized as an over-the-counter (OTC) consumer product rather than a clinical-stage drug candidate.
- Brand names
- Aldevit
- Other names
- Aldevit Syrup
Beyond the preview
Go deeper on Aldevit.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aldevit.